company background image
SHLTN

SHL Telemedicine SWX:SHLTN Stock Report

Last Price

CHF7.30

Market Cap

CHF119.7m

7D

-7.6%

1Y

-52.0%

Updated

09 Dec, 2023

Data

Company Financials

SHL Telemedicine Ltd.

SWX:SHLTN Stock Report

Mkt Cap: CHF119.7m

SHLTN Stock Overview

SHL Telemedicine Ltd., together with its subsidiaries, develops and markets personal telemedicine solutions in Israel, Europe, and internationally.

About the company

SHLTN fundamental analysis
Snowflake Score
Valuation1/6
Future Growth0/6
Past Performance0/6
Financial Health6/6
Dividends0/6

Rewards

Risk Analysis

Highly volatile share price over the past 3 months
Earnings have declined by 58.9% per year over past 5 years
Shareholders have been diluted in the past year

SHL Telemedicine Ltd. Competitors

Ascom Holding

SWX:ASCN

CHF295.2m

IVF Hartmann Holding

SWX:VBSN

CHF261.1m

COLTENE Holding

SWX:CLTN

CHF386.0m

Safe Fertility Group

SET:SAFE

฿5.1b

Price History & Performance

Summary of all time highs, changes and price drops for SHL Telemedicine
Historical stock prices
Current Share PriceCHF7.30
52 Week HighCHF15.20
52 Week LowCHF6.70
Beta0.34
1 Month Change-7.59%
3 Month Change-14.62%
1 Year Change-51.97%
3 Year Change-21.51%
5 Year Change17.74%
Change since IPO-82.20%

Recent News & Updates

We Think SHL Telemedicine Ltd.'s (VTX:SHLTN) CEO Compensation Package Needs To Be Put Under A Microscope

Dec 01
We Think SHL Telemedicine Ltd.'s (VTX:SHLTN) CEO Compensation Package Needs To Be Put Under A Microscope

Is SHL Telemedicine (VTX:SHLTN) A Risky Investment?

Oct 28
Is SHL Telemedicine (VTX:SHLTN) A Risky Investment?

Is SHL Telemedicine (VTX:SHLTN) Using Debt In A Risky Way?

Jun 23
Is SHL Telemedicine (VTX:SHLTN) Using Debt In A Risky Way?

Recent updates

We Think SHL Telemedicine Ltd.'s (VTX:SHLTN) CEO Compensation Package Needs To Be Put Under A Microscope

Dec 01
We Think SHL Telemedicine Ltd.'s (VTX:SHLTN) CEO Compensation Package Needs To Be Put Under A Microscope

Is SHL Telemedicine (VTX:SHLTN) A Risky Investment?

Oct 28
Is SHL Telemedicine (VTX:SHLTN) A Risky Investment?

Is SHL Telemedicine (VTX:SHLTN) Using Debt In A Risky Way?

Jun 23
Is SHL Telemedicine (VTX:SHLTN) Using Debt In A Risky Way?

SHL Telemedicine Ltd.'s (VTX:SHLTN) Financials Are Too Obscure To Link With Current Share Price Momentum: What's In Store For the Stock?

Mar 05
SHL Telemedicine Ltd.'s (VTX:SHLTN) Financials Are Too Obscure To Link With Current Share Price Momentum: What's In Store For the Stock?

Are SHL Telemedicine's (VTX:SHLTN) Statutory Earnings A Good Guide To Its Underlying Profitability?

Feb 12
Are SHL Telemedicine's (VTX:SHLTN) Statutory Earnings A Good Guide To Its Underlying Profitability?

What Percentage Of SHL Telemedicine Ltd. (VTX:SHLTN) Shares Do Insiders Own?

Jan 21
What Percentage Of SHL Telemedicine Ltd. (VTX:SHLTN) Shares Do Insiders Own?

Investors Who Bought SHL Telemedicine (VTX:SHLTN) Shares A Year Ago Are Now Up 120%

Jan 04
Investors Who Bought SHL Telemedicine (VTX:SHLTN) Shares A Year Ago Are Now Up 120%

What Do The Returns At SHL Telemedicine (VTX:SHLTN) Mean Going Forward?

Dec 01
What Do The Returns At SHL Telemedicine (VTX:SHLTN) Mean Going Forward?

Shareholder Returns

SHLTNCH HealthcareCH Market
7D-7.6%-0.4%1.4%
1Y-52.0%2.4%-1.1%

Return vs Industry: SHLTN underperformed the Swiss Healthcare industry which returned 2.4% over the past year.

Return vs Market: SHLTN underperformed the Swiss Market which returned -1.1% over the past year.

Price Volatility

Is SHLTN's price volatile compared to industry and market?
SHLTN volatility
SHLTN Average Weekly Movement9.1%
Healthcare Industry Average Movement5.1%
Market Average Movement3.5%
10% most volatile stocks in CH Market7.1%
10% least volatile stocks in CH Market1.6%

Stable Share Price: SHLTN is more volatile than 90% of Swiss stocks over the past 3 months, typically moving +/- 9% a week.

Volatility Over Time: SHLTN's weekly volatility (9%) has been stable over the past year, but is still higher than 75% of Swiss stocks.

About the Company

FoundedEmployeesCEOWebsite
1987402Erez Nachtomyhttps://www.shl-telemedicine.com

SHL Telemedicine Ltd., together with its subsidiaries, develops and markets personal telemedicine solutions in Israel, Europe, and internationally. It offers smartheart, a personal mobile 12 lead ECG device that enables the detection of heart attacks; CardioSen’C, a personal cellular-digital 12-lead ECG transmitter device; Cardio’B, a portable device to transmit a 12-lead ECG; and Cardio Beeper 12/12, a hand-held ECG transmitter device for personal use that transmits a full ECG reading to the monitoring center. The company also provides central communication module, a telecommunication device that transmits medical data to its telemedicine centers from various medical monitoring devices; TeleWeight, a trans-telephonic weight monitoring device for personal use; TelePress, a remote blood pressure monitoring device for personal use; TeleBreather, a remote electronic handheld device to test the working of lungs; and TelePulse Oximeter, an electronic handheld diagnostic device to measure the saturation level of oxygen in blood, as well as pulse rate.

SHL Telemedicine Ltd. Fundamentals Summary

How do SHL Telemedicine's earnings and revenue compare to its market cap?
SHLTN fundamental statistics
Market CapCHF119.66m
Earnings (TTM)-CHF2.04m
Revenue (TTM)CHF50.24m

2.4x

P/S Ratio

-58.7x

P/E Ratio

Is SHLTN overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report
SHLTN income statement (TTM)
RevenueUS$57.10m
Cost of RevenueUS$32.03m
Gross ProfitUS$25.08m
Other ExpensesUS$27.40m
Earnings-US$2.32m

Last Reported Earnings

Jun 30, 2023

Next Earnings Date

n/a

Earnings per share (EPS)-0.14
Gross Margin43.92%
Net Profit Margin-4.06%
Debt/Equity Ratio16.9%

How did SHLTN perform over the long term?

See historical performance and comparison